Home Conference Coverage

Conference Coverage

Senior woman with lung cancer during medical visit

WCLC 2019: Updates from the Pembrolizumab Clinical Development Program

Peter Hofland, Ph.D -

AACC 2019: Direct-to-Consumer Genetic Testing, Precision Medicine, and Breast Cancer Treatment

Danielle Garcia -
Scientist in biomedical laboratory.

Personalized Gene-edited Immune Cell Therapy may help Patients with Solid Cancers

Peter Hofland, Ph.D -
Golden Gate Bridge view at foggy morning, San Francisco, California,

Early Promise for Pancreatic Cancer Patients Treated with Immune Cell therapy

Peter Hofland, Ph.D -
The ceramic dragon fountain in the Parc Guell designed by Antoni Gaudi, Barcelona, Spain.

Combination of Targeted Therapies Improves Survival in Advanced Colorectal Cancers

Danielle Garcia -

Acalabrutinib Significantly Improves Progression-Free Survival in Chronic Lymphocytic Leukemia

Peter Hofland, Ph.D -
General views of the 55th Annual Meeting of the American Association of Clinical Oncology (ASCO) - held in the McCormick Place in Chicago, Ill. Courtesy: 2019 ? ASCO/Luke Franke 2019.

RC48-ADC Shows Clinically Meaningful Results in Advanced HER2+ Urothelial Cancer

Peter Hofland, Ph.D -
General views of the 55th Annual Meeting of the American Association of Clinical Oncology (ASCO) - held in the McCormick Place in Chicago, Ill. Courtesy: 2019 ? ASCO/Max Gersh.

Majority of Gynecologic Oncologists have Experienced Sexual Harassment

Danielle Garcia -
General view of the 55th Annual Meeting of the American Society of Oncology (ASCO). Courtesey: 2019 ? ASCO/Kristen Norman 2019.

Changing Clinical Trial Enrollment Criteria Dramatically Increases Participation of Eligible Patients...

Peter Hofland, Ph.D -
Exhibition booth Seattle Genetics - ASCO 2019 | Courtsey: Emila Duaerte / Sunvalley Communication

Brentuximab Vedotin Continues to Demonstrate Superior Clinical Activity

Peter Hofland, Ph.D -
123...24Page 1 of 24

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.